Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer (DTC) - organ dosimetry
Citation: Unpublished 2015 JunDepartment: Medicine/Nuclear MedicineForm of publication: Poster PresentationYear: 2015Conference information: MedStar Washington Hospital Center: Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2015, Baltimore, MD, Fiscal year: FY2015Local accession number: 2015_188Date added to catalog: 2016-06-09Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |